These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7623866)

  • 1. The rodent dominant lethal assay: a proposed format for data presentation that alerts to pseudo-dominant lethal effects.
    Ashby J; Clapp MJ
    Mutat Res; 1995 Aug; 330(1-2):209-18. PubMed ID: 7623866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary report of the Working Group on Mammalian Germ Cell Tests.
    Adler ID; Shelby MD; Bootman J; Favor J; Generoso W; Pacchierotti F; Shibuya T; Tanaka N
    Mutat Res; 1994 Jun; 312(3):313-8. PubMed ID: 7514743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of results from a collaborative study of the dominant lethal assay.
    James DA; Smith DM
    Mutat Res; 1982 Aug; 97(4):303-14. PubMed ID: 7121502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of alternative distributions of postimplantation death in the dominant lethal assay.
    Smith DM; James DA
    Mutat Res; 1984 Sep; 128(2):195-206. PubMed ID: 6472312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A guide for mutagenicity testing using the dominant lethal assay.
    Green S; Lavappa KS; Manandhar M; Sheu CJ; Whorton E; Springer JA
    Mutat Res; 1987 Oct; 189(2):167-74. PubMed ID: 3657832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Commission for Protection Against Environmental Mutagens and Carcinogens. Genetic risk extrapolation from animal data to human disease. A Taskgroup Report. No. 00105.
    Favor J; Layton D; Sega G; Wassom J; Burkhart J; Douglas G; Dearfield K; Brusick D
    Mutat Res; 1995 Aug; 330(1-2):23-34. PubMed ID: 7623868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prolonged chemical treatment with cyclophosphamide and 6-mercaptopurine in the dominant lethal test system.
    Moreland FM; Sheu CW; Springer JA; Green S
    Mutat Res; 1981 Oct; 90(2):193-9. PubMed ID: 7199118
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimutagenic effects on male germ cells of mice.
    Renner HW; Knoll M
    Mutat Res; 1984; 140(2-3):127-9. PubMed ID: 6749171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of specific-locus and dominant lethal mutations in male mice by trophosphamide.
    Ehling UH; Neuhäuser-Klaus A
    Mutat Res; 1994 May; 307(1):229-36. PubMed ID: 7513801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks.
    Anderson D; Bishop JB; Garner RC; Ostrosky-Wegman P; Selby PB
    Mutat Res; 1995 Aug; 330(1-2):115-81. PubMed ID: 7623863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of dominant lethal mutations by Ascaris trypsin inhibitor in male mice.
    Blaszkowska J
    Reprod Toxicol; 2010 Jan; 29(1):113-9. PubMed ID: 19737609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dominant lethal and heritable translocation methodologies.
    Anderson D; Hodge MC; Palmer S; Purchase IF
    Mutat Res; 1981 Dec; 85(6):417-29. PubMed ID: 7339488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity of lomefloxacin--an antibacterial drug in somatic and germ cells of Swiss albino mice in vivo.
    Singh AC; Kumar M; Jha AM
    Mutat Res; 2003 Feb; 535(1):35-42. PubMed ID: 12547281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutagenic effect of nitrosodimethylurea in male mice. Induction of dominant lethal mutations and chromosome aberrations in germ cells; genotype influence on the clastogenic effect in bone marrow cells].
    Malashenko AM; Beskova TB; Vasil'eva SV
    Genetika; 1997 Apr; 33(4):524-31. PubMed ID: 9206667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heritable translocation test and dominant-lethal assay in mice with methyl methanesulfonate.
    Lang R; Adler ID
    Mutat Res; 1977; 48(1):75-88. PubMed ID: 189187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-Butadiene working group report.
    Adler ID; Cochrane J; Osterman-Golkar S; Skopek TR; Sorsa M; Vogel E
    Mutat Res; 1995 Aug; 330(1-2):101-14. PubMed ID: 7623862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of phase specificity of in vivo germ cell mutagens in an in vitro germ cell system.
    Habas K; Anderson D; Brinkworth M
    Toxicology; 2016 Apr; 353-354():1-10. PubMed ID: 27059372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between early deaths and implants in control and mutagen-treated CD-1 mice in dominant lethal assays.
    Anderson D; McGregor DB; Weight TM
    Mutat Res; 1981 Apr; 81(2):187-96. PubMed ID: 7195460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of the dominant lethal test in the freshwater mollusk Biomphalaria glabrata (Say, 1818).
    Nakano E; Watanabe LC; Ohlweiler FP; Pereira CA; Kawano T
    Mutat Res; 2003 Apr; 536(1-2):145-54. PubMed ID: 12694755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rodent dominant lethal assay: regulatory questions concerning appraisal of an industrial chemical as exemplified by 1,3-butadiene.
    Brooke IM; Smith AJ
    Mutat Res; 1995 Nov; 332(1-2):119-21. PubMed ID: 7500986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.